Sacituzumab Govitecan In TNBC — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts Dana Farber Cancer Institute, Boston, Massachusetts Massachusetts General Hospital, Boston, Massachusetts Massachusetts General Hospital - North Shore Cancer Center, Danvers, Massachusetts Massachusetts General Hospital at Newton-Wellesley Hospital, Newton, Massachusetts Last updated October 2025